» Articles » PMID: 25656439

A Regression Tree Approach to Identifying Subgroups with Differential Treatment effects

Overview
Journal Stat Med
Publisher Wiley
Specialty Public Health
Date 2015 Feb 7
PMID 25656439
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

In the fight against hard-to-treat diseases such as cancer, it is often difficult to discover new treatments that benefit all subjects. For regulatory agency approval, it is more practical to identify subgroups of subjects for whom the treatment has an enhanced effect. Regression trees are natural for this task because they partition the data space. We briefly review existing regression tree algorithms. Then, we introduce three new ones that are practically free of selection bias and are applicable to data from randomized trials with two or more treatments, censored response variables, and missing values in the predictor variables. The algorithms extend the generalized unbiased interaction detection and estimation (GUIDE) approach by using three key ideas: (i) treatment as a linear predictor, (ii) chi-squared tests to detect residual patterns and lack of fit, and (iii) proportional hazards modeling via Poisson regression. Importance scores with thresholds for identifying influential variables are obtained as by-products. A bootstrap technique is used to construct confidence intervals for the treatment effects in each node. The methods are compared using real and simulated data.

Citing Articles

An Approach for Combining Clinical Judgment with Machine Learning to Inform Medical Decision Making: Analysis of Nonemergency Surgery Strategies for Acute Appendicitis in Patients with Multiple Long-Term Conditions.

Moler-Zapata S, Hutchings A, Grieve R, Hinchliffe R, Smart N, Moonesinghe S Med Decis Making. 2024; 44(8):944-960.

PMID: 39440442 PMC: 11542320. DOI: 10.1177/0272989X241289336.


BioPred: an R package for biomarkers analysis in precision medicine.

Liu Z, Sun Y, Huang X Bioinformatics. 2024; 40(10).

PMID: 39374538 PMC: 11483108. DOI: 10.1093/bioinformatics/btae592.


Potential clinical impact of predictive modeling of heterogeneous treatment effects: scoping review of the impact of the PATH Statement.

Selby J, Maas C, Fireman B, Kent D medRxiv. 2024; .

PMID: 38766150 PMC: 11100853. DOI: 10.1101/2024.05.06.24306774.


5-EPIFAT trial protocol: a multi-center, randomized, placebo-controlled trial of the efficacy of pharmacotherapy for fatigue using methylphenidate, bupropion, ginseng, and amantadine in advanced cancer patients on active treatment.

Miladinia M, Jahangiri M, White S, Karimpourian H, Inno A, Chan S Trials. 2024; 25(1):230.

PMID: 38570861 PMC: 10988831. DOI: 10.1186/s13063-024-08078-w.


Characteristics of Gait Event and Muscle Activation Parameters of the Lower Limb on the Affected Side in Patients With Hemiplegia After Stroke: A Pilot Study.

Seo J, Kang G, Kim C, Jung J, Kim J, Kang H Arch Rehabil Res Clin Transl. 2024; 5(4):100274.

PMID: 38163027 PMC: 10757156. DOI: 10.1016/j.arrct.2023.100274.


References
1.
Lipkovich I, Dmitrienko A, Denne J, Enas G . Subgroup identification based on differential effect search--a recursive partitioning method for establishing response to treatment in patient subpopulations. Stat Med. 2011; 30(21):2601-21. DOI: 10.1002/sim.4289. View

2.
Ciampi A, Negassa A, Lou Z . Tree-structured prediction for censored survival data and the Cox model. J Clin Epidemiol. 1995; 48(5):675-89. DOI: 10.1016/0895-4356(94)00164-l. View

3.
Mehta S, Shelling A, Muthukaruppan A, Lasham A, Blenkiron C, Laking G . Predictive and prognostic molecular markers for cancer medicine. Ther Adv Med Oncol. 2011; 2(2):125-48. PMC: 3126011. DOI: 10.1177/1758834009360519. View

4.
Italiano A . Prognostic or predictive? It's time to get back to definitions!. J Clin Oncol. 2011; 29(35):4718. DOI: 10.1200/JCO.2011.38.3729. View

5.
Song C, Zhang H . Comments on Fifty Years of Classification and Regression Trees. Int Stat Rev. 2015; 82(3):359-361. PMC: 4380222. DOI: 10.1111/insr.12060. View